Sfoglia per AUTORE
NAVONE ND
Collezione AOU San Luigi di Orbassano

  

Items : 5

A20 in Multiple Sclerosis and Parkinson's Disease: Clue to a Common Dysregulation of Anti-Inflammatory Pathways? in Neurotoxicity research / Neurotox Res. 2017 Jul;32(1):1-7. doi: 10.1007/s12640-017-9724-y. Epub 2017 Mar 23.
2017
AOU San Luigi di Orbassano

Perga S; Martire S; Montarolo F; Navone ND; Calvo A; Fuda G; Marchet A; Leotta D; Chiò A; Bertolotto A;

A gene expression study denies the ability of 25 candidate biomarkers to predict the interferon-beta treatment response in multiple sclerosis patients. in Journal of neuroimmunology / J Neuroimmunol. 2016 Mar 15;292:34-9. doi: 10.1016/j.jneuroim.2016.01.010. Epub 2016 Jan 16.
2016
AOU San Luigi di Orbassano

Martire S; Navone ND; Montarolo F; Perga S; Bertolotto A;

Monocytes and CD4+ T cells contribution to the under-expression of NR4A2 and TNFAIP3 genes in patients with multiple sclerosis. in Journal of neuroimmunology / J Neuroimmunol. 2014 Jul 15;272(1-2):99-102. doi: 10.1016/j.jneuroim.2014.04.017. Epub 2014 May 10.
2014
AOU San Luigi di Orbassano

Navone ND; Perga S; Martire S; Berchialla P; Malucchi S; Bertolotto A;

Classification of individuals based on ex-vivo glatiramer acetate-induced interferon-? and interleukin-4 response. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2012 Oct;18(10):1484-92. doi: 10.1177/1352458512440349. Epub 2012 May 4.
2012
AOU San Luigi di Orbassano

Gilli F; Navone ND; Valentino P; Granieri L; Perga S; Malucchi S; Bertolotto A;

Loss of braking signals during inflammation: a factor affecting the development and disease course of multiple sclerosis. in Archives of neurology / Arch Neurol. 2011 Jul;68(7):879-88. doi: 10.1001/archneurol.2011.32. Epub 2011 Mar 14.
2011
AOU San Luigi di Orbassano

Gilli F; Navone ND; Perga S; Marnetto F; Caldano M; Capobianco M; Pulizzi A; Malucchi S; Bertolotto A;